AstraZeneca PLC (NASDAQ:AZN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. AstraZeneca PLC (NASDAQ:AZN ...

The decline in the company's share price came as its shares traded ex-date following the announcement of a ₹32 per share ...

The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 ...

The pound, up 7% this year against the dollar as investors turn away from U.S. assets in response to heightened U.S. policy ...

GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

The FTSE 100 has gained nearly 10% this year to hit record highs this week, beating the STOXX 600, which is up 7.5%.

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

With the aim of being the largest life sector by 2035 behind only the US and China, the UK government is ramping up commercialisation.

Sino Biopharm will buy the 95.1 percent of the Chinese developer of novel biologic drugs for cancer treatment that it does not already own, the Beijing-based company announced late on July 15. LaNova ...

ASX health stocks have rallied 4.9% over the past five days as the sector's largest company CSL lifts 6.3%. ... Read More The ...

Sweden’s Saab boosts 2025 growth outlook after second-quarter results exceed forecasts, fueled by rising global defense demand.